The LTC capacity crisis is not a bed problem. It is a patient turnover problem. When existing residents plateau on inflammation markers, can't meet discharge thresholds, and transfer to hospital at high rates — no number of new beds fixes the waiting list. Healos™ addresses the cellular health of your highest-risk residents, so the beds can move.
1000+
Waiting list per
typical 100-bed
LTC institution
5–7yr
Average Ontario
wait time
(was 2–3 years)
20
High-risk patients
in the Healos™
Trial proposal
100+
Patients per
institution
at contract stage
| ~68% of cardiac residents | On statins — CoQ10 depleted 40–50%. Fatigue prevents rehab completion. |
| ~52% on loop diuretics | K · Mg · Thiamine depleted. Electrolyte-driven arrhythmia and weakness. |
| 40–50% of cardiac patients | Clinical fear of recurrence. Untracked. Multiplies all other risk (×0.4). |
| Complex polypharmacy | 3–6 concurrent medications typical. Drug-nutrient conflicts compound. |
| No GP access (6.5M Canadians) | Residents waiting for LTC often have no regular physician to intercept decline. |
| Healos™ Trial: 20 patients | Targets all five mechanisms simultaneously. 3-month measurable outcome. |
🛡 All protocols pharmacist-reviewed against complex polypharmacy regimens 📋 Monthly H-Index report for every enrolled resident — shareable with clinical team
🔒 HIPAA & PIPEDA · Private Firestore Vault per resident 📊 Contractual inflammation targets — measurable, verifiable outcomes
These are the structural conditions driving the LTC capacity crisis. Healos™ is designed specifically for this gap
— not as wellness, but as a measurable cellular health intervention for your highest-risk residents.
Waiting list per 100-bed LTC institution in many Ontario regions
Current average Ontario LTC wait time — up from 2–3 years
Canadians without a registered family physician (2024)
CoQ10 depletion in statin patients — the primary energy deficit driving care burden
The mechanism: When LTC residents have unaddressed drug-nutrient depletions, subclinical chronic inflammation, and mitochondrial energy deficits — they do not meet discharge criteria, they transfer to hospital at higher rates, and they require more intensive nursing intervention per day. Each of these outcomes directly lengthens your waiting list and increases your per-resident care cost. Healos™ addresses all three mechanisms simultaneously in a structured, pharmacist-reviewed, monthly-tracked program.
The Trial is structured to protect your institution. You select the patients. You set the
outcome expectations. We deliver the data. The long-term contract is conditional on
hitting the agreed targets.
Structured to demonstrate measurable outcome before full institutional commitment
- Measurable reduction in per-resident nursing intervention frequency
- Inflammation marker improvement documented in clinical record
- First LTC institution in region offering structured cellular health — market differentiation
- Data package for regulatory and board reporting on care quality
- Monthly H-Index report per resident — clinical picture between physician visits
- hs-CRP and CoQ10 blood panel before/after comparison at Day 91
- Drug-nutrient interaction review flagging unaddressed polypharmacy gaps
- AI-automated daily tracking — near-zero additional nursing workload
- Trial cost per resident: substantially below one acute-care transfer event
- Long-term contract pricing: per-resident monthly fee, volume-discounted at 100+ patients
- Administrative cost: near-zero due to AI automation (no additional headcount)
- Contract conditional on agreed inflammation and care-intensity targets being met
We will respond personally within 48 hours · Proposal includes full pricing, target metrics, and contract terms
How the Healos™ Sovereign Node partnership changes the economics of long-term care delivery
— for institutions that integrate it as a structured resident health programme.

Institutional partnership enquiries: Healos™ is building a network of institutional LTC partners across Ontario and Canada. The Trial is the entry point — the long-term contract (average 100+ residents per institution) is what the partnership becomes. Contact us directly for a proposal specific to your institution's size, patient population, and current care metrics.
Healos™ Patient Programmes

What Healos Does, and What It Doesn't Do
Before anyone spends money on their recovery, they deserve a straight answer to a simple question: what exactly does this do, and what doesn't it do? This page is that answer, written as plainly as we can.
Here is the short answer. Healos™ provides complementary cellular nutrition and structured follow-up for people recovering from heart attack, heart surgery, stroke or congenital heart disease, and for people focused on prevention. Every kit is pharmacist-reviewed against your medication list before it ships. Healos™ doesn't diagnose, treat or prevent disease, prescribe, change your medicines, or replace your cardiologist, neurologist, cardiac rehab or emergency care.
简短的答案: 在为康复花钱之前,每个人都应该得到一个简单问题的直接答案:它到底做什么,不做什么?本页就是这个答案,尽可能写得直白。Healos™ 为心梗、心脏手术、卒中或先心病后正在康复的人以及关注预防的人,提供辅助的细胞级营养和结构化跟进;每份营养包发货前都由药剂师按你的用药清单审核。Healos™ 不诊断、不治疗、不预防疾病,不开处方、不改变你的药物,也不替代心脏科医生、神经科医生、心脏康复或急救。
Modern medicine is irreplaceable for diagnosis, emergencies, procedures and prescriptions. But most of recovery happens in the months between appointments, where support is thin. About 18% of heart attack survivors have another major event within the first year (Jernberg et al., European Heart Journal, 2015), and only about 24% of eligible US adults attend cardiac rehab, whose structure ends with the last session (Ritchey et al., 2020).
Healos™ is built for that space: what medicines and procedures aren't designed to do, such as nutrients commonly depleted by surgery and medicines, the body's oxidative load and the everyday factors that shape recovery (see one inflammation, three hearts).
Healos™ 为什么存在:复诊之间的空白: 现代医学在诊断、急救、手术和处方上不可替代,但康复的大部分发生在复诊之间的几个月里,那里的支持很少:约 18% 的心梗幸存者第一年再次发生主要事件(Eur Heart J 2015),美国只有约 24% 的合格成人参加心脏康复,而康复的结构在最后一次课后就结束了(2020)。Healos™ 正为这段空白而建:药物和手术本来不负责的部分,比如手术和药物常消耗的营养素、体内的氧化负担,以及塑造康复的日常因素。
Complementary cellular nutrition in three stages: Detox, Replenish and Repair. Detox focuses on lightening oxidative load; Replenish restores nutrients commonly depleted by surgery and heart medicines; Repair supports the body's own recovery. Products are licensed by Health Canada (NPN).
A medication check before anything ships. You share your diagnosis and medication list; every kit is pharmacist-reviewed against it. Taking warfarin or another blood thinner? Tell us at checkout and your kit is adjusted.
Structured follow-up. Follow-ups at day 30 and day 60 (with a reminder to book your blood test) and a blood-test report review at day 90.
Something to bring to your doctor. A summary of your numbers, sleep, mood and activity that you can share with your care team.
Plans for different situations. The 91-Day Protocol for the first months after an event; Sovereign Monthly · Recovery or Protect for ongoing support, cancel any time; a Single Month with no renewal if you'd like to try first.
Healos™ 做什么: 三个阶段的辅助细胞级营养:排毒、补给、修复——排毒着重减轻氧化负担,补给补回手术和心脏药物常消耗的营养素,修复支持身体自身的恢复;产品获 Health Canada NPN 许可。
发货前的用药核查:你提供诊断和用药清单,每份营养包都经药剂师据此审核;服用华法林或其他抗凝药?结账时告诉我们,营养包会相应调整。
结构化跟进:第 30 天跟进、第 60 天跟进并提醒验血、第 90 天验血报告解读。
可带给医生的内容:一份关于你的数字、睡眠、情绪和活动的摘要,方便与医疗团队分享。
不同情况的方案:事件后头几个月用 91 天方案;长期支持用 Sovereign Monthly · Recovery 或 Protect,随时取消;想先试试可选单月、不续费。
It doesn't diagnose, treat, cure or prevent any disease.
It doesn't prescribe, and it never asks you to stop or change a medicine. Statins, antiplatelets, anticoagulants and blood pressure medicines have strong evidence; Healos runs alongside them (see why supplements alone don't fix heart disease).
It doesn't replace your specialists, cardiac rehab or emergency care. Chest pain, stroke signs or fainting: call 911.
It doesn't interpret your tests or imaging. Your doctor does.
It doesn't promise health outcomes. Recovery varies from person to person.
Healos™ 不做什么: 不诊断、不治疗、不治愈、不预防任何疾病;不开处方,也从不要求你停用或更改任何药物——他汀、抗血小板药、抗凝药和降压药都有强有力的证据,Healos™ 与它们并行;不替代专科医生、心脏康复或急救——胸痛、卒中征兆或晕厥请拨打 911;不解读你的检查或影像,那是医生的工作;不承诺健康结果,每个人的康复各不相同。
Will it interfere with my blood thinner or heart medicines? That's exactly why every kit is pharmacist-reviewed against your medication list before it ships. Some nutrients, such as high-dose omega-3 or CoQ10, can interact with blood thinners; your kit is adjusted for what you take (see the medication-nutrient map).
Should I tell my cardiologist? Yes, always. Bring your Healos summary to appointments; it's designed to support the conversation with your care team.
Can I try one month first? Yes: Sovereign Monthly · Single Month, with no renewal.
Can I buy it in Canada? What currency? Healos is available in Canada and the United States. Plans are priced in US dollars; the Clarity Starter report is priced in Canadian dollars.
What if I have a fluid limit, kidney disease or I'm pregnant? Tell us at checkout; these change what's safe, and your kit is reviewed with that in mind. If you're pregnant or planning pregnancy, check with your specialist first.
大家常问的实际问题:
会不会和我的抗凝药或心脏药冲突?这正是每份营养包发货前都要经药剂师按用药清单审核的原因;高剂量 Omega-3 或 CoQ10 等营养素可能与抗凝药相互作用,你的营养包会根据所服药物调整。
要告诉心脏科医生吗?要,永远要;复诊时带上 Healos™ 摘要,它就是为支持你和医疗团队的沟通而设计的。
能先试一个月吗?可以:Sovereign Monthly · Single Month,不续费。
加拿大能买吗?用什么货币?Healos™ 在加拿大和美国都可购买,方案以美元计价,Clarity Starter 报告以加元计价。
有液体限制、肾病或怀孕怎么办?结账时告诉我们,这些会改变什么是安全的,营养包会据此审核;怀孕或备孕请先咨询专科医生。
Healos does one thing: it supports the space between appointments with complementary nutrition, a pharmacist check against your medicines and structured follow-up you can share with your doctor. It doesn't diagnose, treat or replace anything your care team does. If that's the kind of support you've been missing, two quick questions will point you to the right plan.
结论: Healos™ 只做一件事:用辅助营养、针对你药物的药剂师核查,以及可与医生分享的结构化跟进,支持复诊之间的空白。它不诊断、不治疗,也不替代医疗团队做的任何事。如果这正是你一直缺少的支持,两道题就能帮你找到合适的方案。
Jernberg T, et al. Cardiovascular risk in post-myocardial infarction patients. European Heart Journal. 2015;36(19):1163–1170.
Ritchey MD, et al. Tracking cardiac rehabilitation participation and completion among Medicare beneficiaries. Circulation: Cardiovascular Quality and Outcomes. 2020;13(1):e005902.
Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet. 2010;376(9753):1670–1681.
Healos™ Canada — Integrative cellular recovery for post-cardiac, post-stroke, and ACHD patients.
Canada.USA.Mexico.Japan.China.Singapore.Australia...
SMS & voicemail: 365.909.2567
Ottawa, Ontario, Canada
© 2026 Healos™ Canada · NoHeartAttack.com · Ottawa, Ontario Privacy - Terms - Refunds
Healos™ programmes are dietary supplements and integrative wellness services. They are not medical advice, not medical treatment, and not a substitute for professional medical care.
Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme. In case of cardiac emergency, call 911 immediately. Healos™ Canada